Michael Friebe
Overview
Michael Friebe is a German angel investor specializing in healthcare and medical technology startups. He is the General Partner at 5P Future of Health, a boutique investment firm focusing on digital health and health tech innovations. Friebe's investment strategy centers on transformative ideas in 5P medicine: Prevention, Predictive Medicine, Participative Health, Precision Medicine, and Prolonged Health. He seeks to support startups that align with these principles, aiming to revolutionize healthcare delivery and outcomes. With a background in diagnostic imaging and medical technology, Friebe has been involved in founding and leading companies such as Neuromed GmbH and Tomovation AG. His expertise extends to serving on boards of various R&D companies and acting as an investment partner in medical technology startup funds.
Investment Focus
- Innovative healthcare solutions
- Scalable business models
- Strong founding teams
Portfolio Companies
Reach Michael Friebe directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Michael Friebe
What sectors does Michael Friebe invest in?
Michael Friebe invests in Healthcare, Digital Health, Health Tech and Medical Technology, and is based in North Rhine-Westphalia, Germany. Michael Friebe is listed as a angel investor in the ConnectSafely investor database.
What stage does Michael Friebe invest at?
Michael Friebe backs companies at Seed and Early Stage, writing cheques of 500K - 5M.
Which regions does Michael Friebe invest in?
Michael Friebe invests across Germany and Europe.
What companies has Michael Friebe invested in?
Michael Friebe's portfolio includes Tomovation AG and Neuromed GmbH.
Last updated · Source: ConnectSafely investor database
